Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
Tariffs, Fed Moves & Market Clarity: Tim Bohen on the Road Ahead
Tim Bohen dives into the 'Trump Trade,' renewed tariffs, waning uncertainty, corporate guidance, and what the Fed’s next move means for traders and markets.
Tesla Misses on Earnings, Looks to More Affordable Version
Seth Goldstein, Senior Equity Analyst at Morningstar, discusses Tesla’s earnings report, future guidance, and EV market trends.
Wall Street Wisdom: Peter Tuchman on Empowering Traders Through Education & Capital
Wall Street icon Peter Tuchman dives into Apex Trader Funding’s partnership with Wall Street Global Trading Academy and what it means for the next-gen trader.
SPACs Stage a Comeback: What Investors Need to Know
Matthew Frankel, contributing analyst at The Motley Fool, discusses the recent SPAC resurgence, investor interest, and what the data says about their future.
Atomic-6 CEO Trevor Smith on Protecting Satellites with Impact-Absorbing Space Armor™
Atomic-6 CEO Trevor Smith unveils ultralight rocket parts & “Space Armor” composites, backed by ISS legend Chris Hadfield, revolutionizing debris defense.
Fed Independence at Risk? The White House vs. Jerome Powell
Axios’ Neil Irwin unpacks the political clash as the White House explores legal pathways to dismiss Fed Chair Powell, threatening central bank independence.
